CompaniesOthera Pharmaceuticals

Othera Pharmaceuticals

defunct
About

Defunct Company

Areas of Focus

Categories

Terminally AcquiredBankrupt, Merged, Sold, Renamed or Otherwise Defunct
Clinical Trials (4)
View all

Total Trials

4

As Lead Sponsor

3

As Collaborator

1

Total Enrollment

421

By Phase

PHASE1/PHASE2: 1PHASE2: 3

By Status

COMPLETED: 2UNKNOWN: 1TERMINATED: 1
Clinical Trials Pipeline4 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2004
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
Today
NCT00306488
NCT00485394
Hover over trial bars to see details

Recent Trials

NCT00753168Lead Sponsor
Phase 1-2 Evaluation of OT-730 Eye Drops in Reducing the Intraocular Pressure in Patients With Ocular Hypertension or Open-Angle Glaucoma
PHASE1/PHASE2Completed
48 participants
Started: Sep 30, 2008 · Completed: Dec 31, 2008
NCT00485394Lead Sponsor
The OMEGA Study: Use of Eye Drops to Treat Geographic Atrophy Associated With Age-Related Macular Degeneration (Dry AMD)
PHASE2Unknown
198 participants
Started: Jun 30, 2007
NCT00306488Collaborator
OT-551 Antioxidant Eye Drops to Treat Geographic Atrophy in Age-Related Macular Degeneration
PHASE2Completed
11 participants
Started: Mar 31, 2006 · Completed: Mar 31, 2010
NCT00333060Lead Sponsor
Study of OT-551 Eye Drops to Prevent or Delay Progression of Nuclear Cataracts Following Vitreous Removal
PHASE2Terminated
164 participants
Started: Nov 30, 2005 · Completed: Jan 31, 2008
Funding History (2)
D/A
Aug 4, 2009
Filing
D/A
Jun 23, 2009
Filing
Related Companies
Colby Pharmaceuticals 2012----------------------------------------if You Believe Any Of This Information Is Incorrect
acquired